ID   ESI139-A
AC   CVCL_E7TD
SY   ATTR CM PBiPS4-Sv4F-13
DR   BioSamples; SAMEA117624545
DR   hPSCreg; ESi139-A
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Anexo_dep%C3%B3sito_ATTR+CM+PBiPS4-Sv4F-13.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Documento_Deposito_ATTR+CM+PBiPS4-Sv4F-13.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 13,18
ST   D19S433: 13,14
ST   D21S11: 28.2,30
ST   D2S1338: 17
ST   D3S1358: 17,18
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 23,24
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C165489; Hereditary transthyretin amyloid cardiomyopathy
DI   ORDO; Orphanet_271861; Hereditary ATTR amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//